Nantes University Hospital
Nantes, 44093, France
NCT Number: NCT03860103
To identify fetuses small for their gestational-age who have reached their appropriate growth potential from growth-restricted fetuses due to placental insufficiency is uneasy. Intra Uterine Growth Restriction (IUGR) increases the risk for indicated preterm delivery, neonatal mortality and morbidity. Therefore, improving the knowledge of the placental perfusion is essential to better identify and manage fetal chronic oxygen deprivation associated with placental insufficiency. Thus, the investigators propose to study placental microcirculation with a more efficient Doppler than conventional Doppler use in clinical practice. The Ultrafast Doppler is being able to map placental blood flow and could have potential impact in placental insufficiency diagnosis and prevention. Moreover, this Doppler could discriminate maternal and fetal vascularization.
The hypothesis is that Ultrafast Doppler could help clinician to diagnose and manage preeclampsia and IUGR during pregnancy.
Looking for future studies?
Notify Me18 year–60 year
Female
Observational
Nantes, 44093, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from the 12 week of gestation
Time frame: from the 12 week of gestation
Nantes University Hospital
Other
Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler: an Observational Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04389099
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Vandœuvre-lès-Nancy, France
View Trial DetailsNCT05253781
Anemia, Anemia, Hemolytic
Ajegunle, Lagos, Nigeria
View Trial DetailsNCT06653374
Abruptio Placentae, Asphyxia Neonatorum
Quito, Pichincha, Ecuador
View Trial DetailsNCT03231657
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Barcelona, Spain
View Trial Details